MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with M

Magnesium citrate

Magnesium citrate (magnesium 97.2mg (4mmol)) tablets

No stability information

Stability notes for Magnesium citrate (magnesium 97.2mg (4mmol)) tablets

There are no stability notes for this medicine.

Supplier

Magnesium citrate (magnesium 97.2mg (4mmol)) tablets (Kora Healthcare)

Magnesium citrate 100mg capsules

No stability information

Stability notes for Magnesium citrate 100mg capsules

There are no stability notes for this medicine.

Suppliers (6) of Magnesium citrate 100mg capsules
100 M-Trate capsules (TriOn Pharma Ltd)
Acitra 100mg capsules (Essential-Healthcare Ltd)
Amegac 100mg capsules (Vekade Pharma Ltd)
BioCare Magnesium citrate 100mg capsules (BioCare Ltd)
Magnesium citrate 100mg capsules (Special Order)
Magnesium citrate 100mg capsules (Vega Nutritionals Ltd)

Magnesium citrate 150mg tablets

No stability information

Stability notes for Magnesium citrate 150mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Magnesium citrate 150mg tablets
Acitra 150mg tablets (Essential-Healthcare Ltd)
Lamberts MagAsorb 150mg tablets (Lamberts Healthcare Ltd)
MagCit 150mg tablets (Ennogen Healthcare International Ltd)
MagnaTrate 150mg tablets (TriOn Pharma Ltd)
Magnesium citrate 150mg tablets (Special Order)

Magnesium citrate 200mg tablets

No stability information

Stability notes for Magnesium citrate 200mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Magnesium citrate 200mg tablets
Acitra 200mg tablets (Essential-Healthcare Ltd)
MagCit 200mg tablets (Ennogen Healthcare International Ltd)
MagnaTrate 200mg tablets (TriOn Pharma Ltd)
Magnesium citrate 200mg tablets (Part VIIID Drug Tariff Special Order)
Solgar Magnesium Citrate 200mg tablets (Solgar Vitamin and Herb)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.